NASDAQ:BRLI - Bio-Reference Laboratories Stock Price, Price Target & More

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Bio-Reference Laboratories (NASDAQ:BRLI)

Bio-Reference Laboratories logoBio-Reference Laboratories, Inc. is a clinical testing laboratory, which offers testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a range of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It is focused on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional health care. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology and other tissue analysis. It operates a clinical knowledge management service through its PSIMedica business unit. It also operates a Web-based connectivity portal solution for laboratories and physicians through its CareEvolve subsidiary. Its laboratory testing business consists of routine testing and esoteric testing.

Receive BRLI News and Ratings via Email

Sign-up to receive the latest news and ratings for BRLI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Services


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins4.67%
Return on Equity12.67%
Return on Assets8.38%


Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Bio-Reference Laboratories (NASDAQ:BRLI) Frequently Asked Questions

What is Bio-Reference Laboratories' stock symbol?

Bio-Reference Laboratories trades on the NASDAQ under the ticker symbol "BRLI."

How were Bio-Reference Laboratories' earnings last quarter?

Bio-Reference Laboratories Inc (NASDAQ:BRLI) issued its earnings results on Thursday, December, 18th. The medical research company reported $0.66 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.63 by $0.03. The medical research company earned $227.60 million during the quarter, compared to the consensus estimate of $228.81 million. Bio-Reference Laboratories had a return on equity of 12.67% and a net margin of 4.67%. The company's revenue was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.40 earnings per share. View Bio-Reference Laboratories' Earnings History.

Who are some of Bio-Reference Laboratories' key competitors?

Has Bio-Reference Laboratories been receiving favorable news coverage?

News stories about BRLI stock have been trending somewhat positive this week, according to Accern Sentiment. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Bio-Reference Laboratories earned a coverage optimism score of 0.10 on Accern's scale. They also assigned news headlines about the medical research company an impact score of 45.31 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of Bio-Reference Laboratories?

Shares of BRLI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Bio-Reference Laboratories?

Bio-Reference Laboratories' mailing address is 481 Edward H Ross Dr, ELMWOOD PARK, NJ 07407-3118, United States. The medical research company can be reached via phone at +1-201-7912186.

MarketBeat Community Rating for Bio-Reference Laboratories (BRLI)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  77 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  138
MarketBeat's community ratings are surveys of what our community members think about Bio-Reference Laboratories and other stocks. Vote "Outperform" if you believe BRLI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRLI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Bio-Reference Laboratories (NASDAQ:BRLI) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/21/2016 forward)


Bio-Reference Laboratories (NASDAQ:BRLI) Earnings History and Estimates Chart

Earnings by Quarter for Bio-Reference Laboratories (NASDAQ:BRLI)

Bio-Reference Laboratories (NASDAQ BRLI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
6/8/2015Q215$0.46$0.38$227.33 million$224.00 millionViewListenView Earnings Details
3/5/2015Q115$0.36$0.24$216.40 million$209.00 millionViewListenView Earnings Details
12/18/2014Q414$0.63$0.66$228.81 million$227.60 millionViewListenView Earnings Details
8/27/2014Q314$0.53$0.55$210.44 million$222.10 millionViewListenView Earnings Details
6/5/2014Q214$0.32$0.37$0.1956 million$201.30 millionViewListenView Earnings Details
3/4/2014Q114$0.14$0.11$175.52 million$181.30 millionViewListenView Earnings Details
12/19/2013Q4$0.40$0.40$188.96 million$192.20 millionViewListenView Earnings Details
8/29/2013Q3 2013$0.51$0.53$183.50 million$185.40 millionViewListenView Earnings Details
6/6/2013Q2 2013$0.41$0.41$176.04 million$176.50 millionViewListenView Earnings Details
2/28/2013Q1 2013$0.28$0.31$165.44 million$161.30 millionViewListenView Earnings Details
12/6/20120.46$0.46$175.46 millionViewListenView Earnings Details
8/30/2012Q312$0.43$0.45$0.1737 million$0.1723 millionViewN/AView Earnings Details
6/7/2012$0.32$0.33ViewN/AView Earnings Details
3/1/2012$0.21$0.26ViewN/AView Earnings Details
12/8/2011$0.35$0.37ViewN/AView Earnings Details
8/25/2011$0.34$0.36ViewN/AView Earnings Details
5/26/2011$0.24$0.26ViewN/AView Earnings Details
3/3/2011$0.17$0.28ViewN/AView Earnings Details
12/16/2010$0.30$0.31$124.19 million$126.60 millionViewN/AView Earnings Details
8/26/2010Q3 2010$0.28$0.29ViewN/AView Earnings Details
3/4/2010Q1 2010$0.12$0.14ViewN/AView Earnings Details
12/17/2009Q4 2009$0.22$0.26ViewN/AView Earnings Details
9/2/2009Q3 2009$0.19$0.23ViewN/AView Earnings Details
6/4/2009Q2 2009$0.14$0.17ViewN/AView Earnings Details
3/5/2009Q1 2009$0.09$0.10ViewN/AView Earnings Details
12/18/2008Q4 2008$0.18$0.19ViewN/AView Earnings Details
9/4/2008Q3 2008$0.16$0.17ViewN/AView Earnings Details
6/5/2008Q2 2008$0.14$0.12ViewN/AView Earnings Details
3/6/2008Q1 2008$0.07$0.08ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Bio-Reference Laboratories (NASDAQ:BRLI) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Bio-Reference Laboratories (NASDAQ BRLI) Insider Trading and Institutional Ownership History

Insider Trading History for Bio-Reference Laboratories (NASDAQ:BRLI)

Bio-Reference Laboratories (NASDAQ BRLI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/13/2013Howard DubinettCOOSell20,000$29.40$588,000.00345,138View SEC Filing  
6/27/2013Sam SingerCFOSell4,000$28.95$115,800.00View SEC Filing  
6/26/2013Sam SingerCFOSell6,000$28.50$171,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Bio-Reference Laboratories (NASDAQ BRLI) News Headlines


SEC Filings

Bio-Reference Laboratories (NASDAQ:BRLI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Bio-Reference Laboratories (NASDAQ:BRLI) Income Statement, Balance Sheet and Cash Flow Statement


Bio-Reference Laboratories (NASDAQ BRLI) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.